🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Gao's Triple Eversion Carotid Endarterectomy

Recruitingn/aAges any - anyAllSecond Affiliated Hospital, Zhejiang University, …
NCT06722222 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Carotid endarterectomy (CEA), an important surgical approach for managing carotid plaque, has evolved over more than 70 years but still cannot be applied to all tandem carotid lesions (TCLs) because of the wide range of these lesions. Herein, the investigators introduce an innovative CEA, Gao's triple eversion CEA (GTE-CEA), for the treatment of TCLs.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Meet the diagnostic criteria for TCL stenosis. * Above 70% asymptomatic CCA and ICA stenosis or \> 50% symptomatic CAS confirmed by DSA or CTA before surgery Exclusion Criteria: * Did not meet the diagnostic criteria for CAS * Asymptomatic CAS \< 50% (as confirmed by DSA or CTA before surgery) * With stenosis at the opening of the CCA.
💊

What it tests

  • Gao's triple eversion carotid endarterectomy
📍

Where

1 site
the Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy